Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards

被引：0
|
作者：
Wiese, Michael D. [1 ]
Metcalf, Robert [2 ]
Wechalekar, Mihir D. [3 ]
Spargo, Llew [2 ]
McWilliams, Leah [4 ]
James, Michael [4 ,5 ]
Hill, Catherine [6 ]
Proudman, Susanna [7 ]
机构：
[1] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia
[2] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA, Australia
[3] Royal Adelaide Hosp, Adelaide, SA, Australia
[4] Royal Adelaide Hosp, Dept Rheumatol, Adelaide, SA, Australia
[5] Univ Adelaide, Dept Med, Adelaide, SA, Australia
[6] Queen Elizabeth Hosp, Adelaide, SA, Australia
[7] Univ Adelaide, Adelaide, SA, Australia
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
448
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ARE THE RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICS WITH OR WITHOUT SYNTHETIC DMARDS IN CLINICAL PRACTICE DIFFERENT?
    Hernandez Cruz, B.
    Ariza Ariza, R.
    Caliz Caliz, R.
    Marquez Saavedra, E.
    Navarro Sarabia, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 407 - 407
  • [22] Cardiovascular Disease Risk with Biologics and Tofacitinib Compared to Conventional Synthetic Dmards in Patients with Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] CLINICAL PHENOTYPE AND ULTRASOUND CHARACTERISTICS OF RHEUMATOID ARTHRITIS FLARE AFTER DISCONTINUATION OF CONVENTIONAL SYNTHETIC DMARDS
    Manzo, A.
    Bugatti, S.
    Benaglio, F.
    Sakellariou, G.
    Caporali, R.
    Montecucco, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1287 - 1287
  • [24] A Majority of Early Rheumatoid Arthritis (ERA) Patients Reach Remission By 6 Months in Usual Rheumatology Care
    Rannio, Tuomas
    Asikainen, Juha
    Hannonen, Pekka
    Yli-Kerttula, Timo
    Ekman, Paivi
    Pirila, Laura
    Mali, Markku
    Kuusela, Laura
    Puurtinen-Vilkki, Maija
    Kortelainen, Saara
    Paltta, Johanna
    Taimen, Kirsi
    Makinen, Heidi
    Isomaki, Pia
    Uotila, Terhi
    Kauppi, Markku J.
    Laiho, Kari
    Nyrhinen, Satu
    Sokka-Isler, Tuulikki
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [25] Start DMARDs early in patients with rheumatoid arthritis
    Drugs & Therapy Perspectives, 2002, 18 (6) : 3 - 7
  • [26] Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial
    Kuijper, T. M.
    Luime, J. J.
    de Jong, P. H. P.
    Gerards, A. H.
    van Zeben, D.
    Tchetverikov, I.
    de Sonnaville, P. B. J.
    van Krugten, M. V.
    Grillet, B. A.
    Hazes, J. M. W.
    Weel, A. E. A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (12) : 2119 - 2123
  • [27] Prognostic markers of remission in early rheumatoid arthritis after two years of DMARDS in a clinical setting
    Vazquez, I.
    Graell, E.
    Moll, C.
    Gratacos, J.
    Gomez-Centeno, A.
    Larrosa, M.
    Ercilla, M. G.
    Hernandez, M. V.
    Gomez-Puerta, J. A.
    Saura, C.
    Salvador, G.
    Canete, J. D.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 158 - 158
  • [28] COMPARISON OF TOFACITINIB SAFETY AND EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS, OR TO ONE OR MORE BIOLOGICAL DMARDS
    Charles-Schoeman, C.
    Kremer, J.
    Krishnaswami, S.
    Soma, K.
    Geier, J.
    Zhang, R.
    Strengholt, S.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 271 - 272
  • [29] SYNOVIAL MAST CELLS AND RESPONSES TO SYNTHETIC AND BIOLOGIC DMARDS IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS
    Rivellese, F.
    Nerviani, A.
    Mauro, D.
    Pagani, S.
    Humby, F.
    Pitzalis, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 900 - 901
  • [30] Predicting and deciding on remission in rheumatoid arthritis
    Stucki, G
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (11): : 1039 - 1040
12345